Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo

Jing Yang, Takayuki Ikezoe, Chie Nishioka, Taizo Tasaka, Ayuko Taniguchi, Yoshio Kuwayama, Naoki Komatsu, Kentaro Bandobashi, Kazuto Togitani, H. Phillip Koeffler, Hirokuni Taguchi, Akihito Yokoyama

Blood (2007) 110 (6): 2034–2040.

https://doi.org/10.1182/blood-2007-02-073700

Published: 2007

Journal Articles

ZM447439, a Novel Aurora Kinase Inhibitor, Induces Growth Arrest and Apoptosis of Human Leukemia Cells.

Takayuki Ikezoe, MD, Chie Nishioka, Taizo Tasaka, MD, Ayuko Taniguchi, MD, Naoki Komatsu, MD, Yoshio Kuwayama, MD, Kazuto Togitani, MD, H. Phillip Koeffler, MD, Hirokuni Taguchi, MD

Blood (2006) 108 (11): 1990.

https://doi.org/10.1182/blood.V108.11.1990.1990

Published: 2006

Journal Articles

Minimal Residual Disease (MRD) in Adult T-Cell Leukemia/Lymphoma (ATLL) Evaluated by HTLV-1 Proviral Load and Soluble IL-2 Receptor Level in Peripheral Blood.

Kunihiro Tsukasaki, Shigeki Takemoto, Hirokuni Taguchi, Masato Masuda, Syuichi Ikeda, Shinichiro Yoshida, Hitoshi Suzushima, Naokuni Uike, Yoshio Saburi, Fumio Kawano, Masaomi Yamamura, Eizaburo Sueoka, Masaharu Miyahara, Masao Tomonaga

Blood (2005) 106 (11): 2821.

https://doi.org/10.1182/blood.V106.11.2821.2821

Published: 2005

Journal Articles

The Anti-Tumor Effects of SU11248, a Class III Receptor Tyrosine Kinase Inhibitor, Against a Variety of Human Hematological Malignancies.

Takayuki Ikezoe, MD, Kentaro Bandobashi, MD, Yang Yang, Tsuyako Saito, MD, Kazuto Togitani, MD, Taizo Tasaka, MD, H. Phillip Koeffler, MD, Hirokuni Taguchi, MD

Blood (2005) 106 (11): 2795.

https://doi.org/10.1182/blood.V106.11.2795.2795

Published: 2005

Journal Articles

Anti-Interleukin 6 Receptor Monoclonal Antibody Therapy Reduced Serum Interleukin 4 and IgE Production in Castleman’s Disease.

Blood (2005) 106 (11): 1510.

https://doi.org/10.1182/blood.V106.11.1510.1510

Published: 2005

Journal Articles

Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease

Blood (2005) 106 (8): 2627–2632.

https://doi.org/10.1182/blood-2004-12-4602

Published: 2005

Journal Articles

Role of Protein Kinase C in Expression of Granulocyte Colony Stimulating Factor and Granulocyte-Macrophage Colony Stimulating Factor in Lung Cancer Cells.

Yoshiki Uemura, MD, Makoto Kobayashi, MD, Hideshi Nakata, MD, Tetsuya Kubota, MD, Hirokuni Taguchi, MD.

Blood (2004) 104 (11): 4210.

https://doi.org/10.1182/blood.V104.11.4210.4210

Published: 2004

Journal Articles

Effects of Constitutive Production of Colony-Stimulating Factors by Human Lung Cancer Cells on Invasive Capacity.

Yoshiki Uemura, MD, Makoto Kobayashi, MD, Hideshi Nakata, MD, Tetsuya Kubota, MD, Hirokuni Taguchi, MD.

Blood (2004) 104 (11): 4211.

https://doi.org/10.1182/blood.V104.11.4211.4211

Published: 2004

Journal Articles

HIV-1 Protease Inhibitor Ritonavir Potentiates the Effect of 1,25-Dihydroxyvitamin D 3 to Induce Growth Arrest and Differentiation of Human Myeloid Leukemia Cells Via Inhibition of CYP24.

Takayuki Ikezoe, Yang Yang, Kentaro Bandobashi, Nobuo Sekiguchi, Shuichi Sakai, H. Phillip Koeffler, Hirokuni Taguchi

Blood (2004) 104 (11): 2543.

https://doi.org/10.1182/blood.V104.11.2543.2543

Published: 2004

Journal Articles

Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells

Takayuki Ikezoe, Sakae Tanosaki, Utz Krug, Bingrong Liu, Pinchas Cohen, Hirokuni Taguchi, H. Phillip Koeffler

Blood (2004) 104 (1): 237–242.

https://doi.org/10.1182/blood-2003-07-2203

Published: 2004

Journal Articles

Representational difference analysis using myeloid cells from C/EBPε deletional mice

Tetsuya Kubota, Seiji Kawano, Doris Y. Chih, Yasuko Hisatake, Alexey M. Chumakov, Hirokuni Taguchi, H. Phillip Koeffler

Blood (2000) 96 (12): 3953–3957.

https://doi.org/10.1182/blood.V96.12.3953

Published: 2000

Journal Articles

HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells

Takayuki Ikezoe, Eric S. Daar, Jun-ichi Hisatake, Hirokuni Taguchi, H. Phillip Koeffler

Blood (2000) 96 (10): 3553–3559.

https://doi.org/10.1182/blood.V96.10.3553

Published: 2000

Journal Articles

Mutations of the E2F4 gene in hematological malignancies having microsatellite instability

Naoki Komatsu, Seisho Takeuchi, Takayuki Ikezoe, Taizo Tasaka, Yoshihiro Hatta, Hisanori Machida, Ian K. Williamson, Claus R. Bartram, H. Phillip Koeffler, Hirokuni Taguchi

Blood (2000) 95 (4): 1509–1510.

https://doi.org/10.1182/blood.V95.4.1509.004k33_1509_1510

Published: 2000

Journal Articles

Inheritance of Chromosomally Integrated Human Herpesvirus 6 DNA

Masanori Daibata, Takahiro Taguchi, Yuiko Nemoto, Hirokuni Taguchi, Isao Miyoshi

Blood (1999) 94 (5): 1545–1549.

https://doi.org/10.1182/blood.V94.5.1545

Published: 1999

Journal Articles

Human Herpesvirus 6 (HHV-6)–Positive Burkitt's Lymphoma: Establishment of a Novel Cell Line Infected With HHV-6

Kentaro Bandobashi, Masanori Daibata, Mikio Kamioka, Yuji Tanaka, Ichiro Kubonishi, Hirokuni Taguchi, Yuji Ohtsuki, Isao Miyoshi

Blood (1997) 90 (3): 1200–1207.

https://doi.org/10.1182/blood.V90.3.1200

Published: 1997

NARROW

AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo

ZM447439, a Novel Aurora Kinase Inhibitor, Induces Growth Arrest and Apoptosis of Human Leukemia Cells.

Minimal Residual Disease (MRD) in Adult T-Cell Leukemia/Lymphoma (ATLL) Evaluated by HTLV-1 Proviral Load and Soluble IL-2 Receptor Level in Peripheral Blood.

The Anti-Tumor Effects of SU11248, a Class III Receptor Tyrosine Kinase Inhibitor, Against a Variety of Human Hematological Malignancies.

Anti-Interleukin 6 Receptor Monoclonal Antibody Therapy Reduced Serum Interleukin 4 and IgE Production in Castleman’s Disease.

Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease

Role of Protein Kinase C in Expression of Granulocyte Colony Stimulating Factor and Granulocyte-Macrophage Colony Stimulating Factor in Lung Cancer Cells.

Effects of Constitutive Production of Colony-Stimulating Factors by Human Lung Cancer Cells on Invasive Capacity.

HIV-1 Protease Inhibitor Ritonavir Potentiates the Effect of 1,25-Dihydroxyvitamin D 3 to Induce Growth Arrest and Differentiation of Human Myeloid Leukemia Cells Via Inhibition of CYP24.

Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells

Representational difference analysis using myeloid cells from C/EBPε deletional mice

HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells

Mutations of the E2F4 gene in hematological malignancies having microsatellite instability

Inheritance of Chromosomally Integrated Human Herpesvirus 6 DNA

Human Herpesvirus 6 (HHV-6)–Positive Burkitt's Lymphoma: Establishment of a Novel Cell Line Infected With HHV-6

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only